Novo Nordisk's Christmas Gift To Shareholders: The Wegovy Pill Has Been Approved (NVO)

I was losing hope regarding the oral semaglutide (aka Wegovy pill) gaining FDA approval, but the positive outcome came right before Christmas. I personally think this is the turning point for Novo Nordisk A/S (Hi there, welcome to my profile. My name is Eugenio Catone, I live in Italy and I am 27 years old.In 2023 I graduated in Business Administration and I completed CFA level 1 in 2024. I am currently a Popular Investor on the investing platform eToro, you can see there my public portfolio. My interest in ...